Bambusa Therapeutics, Inc. (BBTX)

Bambusa Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Bambusa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	46.53	50.64	9.36
Short-Term Investments	24.94	39.98	-
Cash & Cash Equivalents	71.48	90.63	9.36
Cash Growth	-	868.03%	-
Other Current Assets	3.82	3.51	0.4
Total Current Assets	75.3	94.13	9.76
Other Long-Term Assets	-	1.58	0
Total Long-Term Assets	-	1.58	0
Total Assets	-	95.71	9.76

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Accounts Payable	-	1.91	0.01
Other Current Liabilities	12.22	7.74	9.3
Total Current Liabilities	12.22	9.65	9.32
Total Liabilities	-	9.65	9.32

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Retained Earnings	-	-54.83	-13.74
Comprehensive Income	-	0.06	-
Shareholders' Equity	-70.96	-49.17	-13.55

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Cash (Debt)	71.48	90.63	9.36
Net Cash (Debt) Growth	-	868.03%	-
Working Capital	63.08	84.48	0.45